Klev Diamanti and his co-workers performed metabolic screening in five key metabolic tissues from 43 multi-organ donors to study metabolic interplay between organs in the development of T2D. The metabolic profiling was performed at Swedish Metabolomics Centre. See the article here:
Diamanti et al. Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Sci Rep. 2019;9(1):9653.